Exploring amygdala structural changes and signaling pathways in postmortem brains: consequences of long-term...

Area of Science:

• Neuroscience
• Toxicology
• Molecular Biology

Background:

• Methamphetamine (METH) addiction can lead to central nervous system (CNS) neurotoxicity via pathways including oxidative stress and apoptosis.
• Long-term METH abuse is associated with detrimental effects on brain structure and function.

Purpose of the Study:

• To investigate the long-term structural impact of METH addiction on the human amygdala.
• To explore the involvement of cAMP response element-binding protein/brain-derived neurotrophic factor (CREB/BDNF) and Akt-1/GSK3 signaling pathways in METH-induced neurotoxicity.

Main Methods:

• Analysis of ten male postmortem brains (controls vs. chronic METH users).
• Techniques included immunohistochemistry, real-time PCR, Tunnel assay, stereology, and biochemical assays for oxidative stress markers (ROS, GSSG, GPX).
• Quantification of CREB, BDNF, Akt-1, GSK3, and TNF-α levels.

Main Results:

• METH significantly decreased BDNF, CREB, Akt-1, and GPX expression.
• METH significantly increased GSSG, ROS, RIPK3, GSK3, and TNF-α levels.
• Evidence of METH-induced inflammation and neurodegeneration in the amygdala, with ROS production linked to CREB/BDNF and Akt-1/GSK3 pathways.

Conclusions:

• Chronic METH use induces significant structural changes and neuroinflammation in the human amygdala.
• The CREB/BDNF and Akt-1/GSK3 signaling pathways are critically involved in METH-induced oxidative stress and neurotoxicity.
• Findings highlight potential therapeutic targets for mitigating METH-related brain damage.